BriaCell Announces Securities Buyback to Purchase up to 10% of Common Shares and up to 10% of Listed Warrants Biotech Investing
BioHarvest Sciences New 20 Tons Per Year Factory Successfully Passes the ISO9001 and ISO22000 Audit Biotech Investing
Clinical Trial of Investigational Epcoritamab in Patients with Relapsed/Refractory B-cell non-Hodgkin's Lymphoma Published in The Lancet Biotech Investing
INVESTIGATION: Halper Sadeh LLP Investigates INOV, SAFM, LMRK, AVCO, TRIL, XENT; Shareholders are Encouraged to Contact the Firm Biotech Investing
AbbVie to Present Data From Its Migraine Portfolio at the 2021 International Headache Congress Biotech Investing
Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with Opdivo® for Treatment of HER2-Expressing Solid Tumors Biotech Investing
Lexaria Begins Investigational New Drug Enabling Program for DehydraTECH-CBD for Hypertension Biotech Investing
More than 230 Bristol Myers Squibb Employees Pedal Across the U.S. to Advance Cancer Research in Seventh Annual Coast 2 Coast 4 Cancer Ride Biotech Investing
